Clinical Trials Directory

Trials / Completed

CompletedNCT01633671

NT-proBNP as a Tool for the Detection of Acute Pulmonary Artery Embolism (APE)

NT-proBNP: a Useful Tool for the Detection of Acute Pulmonary Artery Embolism in Post-surgical Patients

Status
Completed
Phase
Study type
Observational
Enrollment
44 (actual)
Sponsor
University of Ulm · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In patients with suspected APE (Acute Pulmonary Embolism) referred to the intensive care unit (ICU)after major surgery, serum NT-proBNP (N-terminal proBNP), Troponin-I and D-dimers were measured according to the standard hospital protocol. To definitively confirm or exclude APE, all patients underwent an angiographic CT-scan of the thorax.

Detailed description

In patients with suspected APE referred to the intensive care unit after major surgery, serum NT-proBNP, Troponin-I and D-dimers were measured according to the standard hospital protocol. Blood samples were obtained within one hour after the onset of clinical symptoms. Definitive confirmation or exclusion of APE was performed with an angiographic CT-scan of the thorax.

Conditions

Timeline

Start date
2008-11-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2012-07-04
Last updated
2012-07-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01633671. Inclusion in this directory is not an endorsement.

NT-proBNP as a Tool for the Detection of Acute Pulmonary Artery Embolism (APE) (NCT01633671) · Clinical Trials Directory